Recently, miRNA-93 participates in drug resistance of tumor cells by targeting on genes or signaling pathways linked to resistance development, such as the PI3K/Akt signaling pathway and the expression of anti-apoptotic proteins in pancreatic cancer [30]. Here, AKT1 is linked to neoplasm.